» Articles » PMID: 20567677

Experience with Nerve Allograft Transplantation

Overview
Specialty General Surgery
Date 2010 Jun 23
PMID 20567677
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Nerve allograft transplantation should be used for the repair of devastating peripheral nerve injuries that cannot be reconstructed through traditional means such as autologous nerve grafting or nerve transfer procedures. The risks of required systemic immunosuppression, although only temporary for nerve allograft recipients, preclude widespread use of this treatment modality. Translational research has led to several advancements in this field including the use of preoperative allograft cold preservation in University of Wisconsin organ preservation solution and inclusion of tacrolimus as part of the immunosuppressive regimen. Investigation of how to further diminish nerve allograft immunogenicity, speed neuroregeneration by use of agents such as tacrolimus, and promote preferential motor regeneration will further advance this field with the goal of restoring optimal function while minimizing patient morbidity.

Citing Articles

Updates in peripheral nerve surgery of the upper extremity: diagnosis and treatment options.

Tan R, Jeyaratnam S, Lim A Ann Transl Med. 2023; 11(11):391.

PMID: 37970602 PMC: 10632574. DOI: 10.21037/atm-23-1500.


Nerve regeneration using decellularized tissues: challenges and opportunities.

Mahdian M, Tabatabai T, Abpeikar Z, Rezakhani L, Khazaei M Front Neurosci. 2023; 17:1295563.

PMID: 37928728 PMC: 10620322. DOI: 10.3389/fnins.2023.1295563.


End-to-Side vs. Free Graft Nerve Reconstruction-Experimental Study on Rats.

Czarnecki P, Huber J, Szymankiewicz-Szukala A, Gorecki M, Romanowski L Int J Mol Sci. 2023; 24(13).

PMID: 37445608 PMC: 10341830. DOI: 10.3390/ijms241310428.


Polyethylene Glycol Fusion of Nerve Injuries: Review of the Technique and Clinical Applicability.

Van Nest D, Kahan D, Ilyas A J Hand Microsurg. 2021; 13(2):49-54.

PMID: 33867761 PMC: 8041495. DOI: 10.1055/s-0040-1718651.


Effective decellularization of human nerve matrix for regenerative medicine with a novel protocol.

Nieto-Nicolau N, Lopez-Chicon P, Farinas O, Bolivar S, Udina E, Navarro X Cell Tissue Res. 2021; 384(1):167-177.

PMID: 33471198 DOI: 10.1007/s00441-020-03317-3.


References
1.
Evans P, Mackinnon S, Levi A, Wade J, Hunter D, Nakao Y . Cold preserved nerve allografts: changes in basement membrane, viability, immunogenicity, and regeneration. Muscle Nerve. 1998; 21(11):1507-22. DOI: 10.1002/(sici)1097-4598(199811)21:11<1507::aid-mus21>3.0.co;2-w. View

2.
Wang M, Gold B . Comparative dose-dependence study of FK506 and cyclosporin A on the rate of axonal regeneration in the rat sciatic nerve. J Pharmacol Exp Ther. 1997; 282(2):1084-93. View

3.
Gold B, Gordon H, Wang M . Efficacy of delayed or discontinuous FK506 administrations on nerve regeneration in the rat sciatic nerve crush model: lack of evidence for a conditioning lesion-like effect. Neurosci Lett. 1999; 267(1):33-6. DOI: 10.1016/s0304-3940(99)00333-x. View

4.
Hricik D . Withdrawal of immunosuppression: implications for composite tissue allograft transplantation. Transplant Proc. 1998; 30(6):2721-3. DOI: 10.1016/s0041-1345(98)00796-9. View

5.
Best T, Mackinnon S, Midha R, Hunter D, Evans P . Revascularization of peripheral nerve autografts and allografts. Plast Reconstr Surg. 1999; 104(1):152-60. View